Brinton Pharmaceuticals Limited, an innovation-based multinational, announced the appointment of Amit Jain as the President & Head of Domestic Business.

The strategic appointment comes at a time when Brinton Pharma with an impressive portfolio in diversified areas like dermatology, paediatric, respiratory and family physician specialities is further strengthening its global and domestic operations.

Jain's impressive track record, extensive experience and professional approach in the industry position him to play a crucial and constructive role in driving the company's growth besides consolidating its position as a leader in the domestic market.

With over 27 years of expertise in key leadership positions at reputable pharma companies,  Jain brings a wealth of knowledge to Brinton.

Sharing his excitement on the new appointment, Rahukumar Darda, Chairman and Managing Director, Brinton Pharma, said Jain had consistently delivered exceptional results throughout his career, focusing on business growth, forecasting, operational excellence, and strategic management.

In his new position, Jain will have oversight of Brinton's domestic operations, including business development, sales, and marketing, added Darda.

Jain expressed his honor at joining Brinton's vibrant team and his anticipation of leading the company's domestic business to unprecedented success. "I am committed to driving innovation, delivering exceptional value to customers, and capitalizing on the vast growth opportunities within the market.  I am excited about my role at Brinton," he said.

Brinton have strong presence in more than 32 countries. The company’s products are manufactured at world-class multi-locational research and manufacturing partner facilities, meeting the most stringent demands of global regulatory authorities including WHO, GMP, PICS, PPB, NDA amongst others.